HUP0401850A3 - Donepezil salts for producing pharmaceutical composition - Google Patents
Donepezil salts for producing pharmaceutical compositionInfo
- Publication number
- HUP0401850A3 HUP0401850A3 HU0401850A HUP0401850A HUP0401850A3 HU P0401850 A3 HUP0401850 A3 HU P0401850A3 HU 0401850 A HU0401850 A HU 0401850A HU P0401850 A HUP0401850 A HU P0401850A HU P0401850 A3 HUP0401850 A3 HU P0401850A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- producing pharmaceutical
- donepezil salts
- donepezil
- salts
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical class O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
UAA200704106A UA88481C2 (ru) | 2004-09-15 | 2005-09-12 | Донепезила фумарат, пригодный для получения фармацевтических композиций |
PCT/HU2005/000102 WO2006030249A1 (en) | 2004-09-15 | 2005-09-12 | Donepezil salts suitable for the preparation of pharmaceutical compositions |
CNA2005800348076A CN101039910A (zh) | 2004-09-15 | 2005-09-12 | 适合制备药物组合物的多奈哌齐盐 |
CZ20070248A CZ2007248A3 (cs) | 2004-09-15 | 2005-09-12 | Donepezilové soli vhodné pro prípravu farmaceutických kompozic |
EP05787910A EP1817286A1 (en) | 2004-09-15 | 2005-09-12 | Donepezil salts suitable for the preparation of pharmaceutical compositions |
PL382842A PL382842A1 (pl) | 2004-09-15 | 2005-09-12 | Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznych |
EA200700637A EA200700637A1 (ru) | 2004-09-15 | 2005-09-12 | Соли донепезила, подходящие для получения фармацевтических композиций |
RU2007114082/04A RU2382032C2 (ru) | 2004-09-15 | 2005-09-12 | Соли донепезила, подходящие для получения фармацевтических композиций |
SK5034-2007A SK50342007A3 (sk) | 2004-09-15 | 2005-09-12 | Donepezilové soli vhodné na prípravu farmaceutických kompozícií |
US11/662,867 US20080194628A1 (en) | 2004-09-15 | 2005-12-09 | Donepezil Salts Suitable for the Preparation of Pharmaceutical Compositions |
IL181827A IL181827A0 (en) | 2004-09-15 | 2007-03-08 | Donepezil salts suitable for the preparation of pharmaceutical compositions |
BG109855A BG109855A (bg) | 2004-09-15 | 2007-04-13 | Донепезилови соли подходящи за получаване на фармацевтични състави |
NO20071912A NO20071912L (no) | 2004-09-15 | 2007-04-16 | Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0401850D0 HU0401850D0 (en) | 2004-11-29 |
HUP0401850A2 HUP0401850A2 (en) | 2006-11-28 |
HUP0401850A3 true HUP0401850A3 (en) | 2008-03-28 |
Family
ID=89985497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080194628A1 (hu) |
EP (1) | EP1817286A1 (hu) |
CN (1) | CN101039910A (hu) |
BG (1) | BG109855A (hu) |
CZ (1) | CZ2007248A3 (hu) |
EA (1) | EA200700637A1 (hu) |
HU (1) | HUP0401850A3 (hu) |
IL (1) | IL181827A0 (hu) |
NO (1) | NO20071912L (hu) |
PL (1) | PL382842A1 (hu) |
RU (1) | RU2382032C2 (hu) |
SK (1) | SK50342007A3 (hu) |
UA (1) | UA88481C2 (hu) |
WO (1) | WO2006030249A1 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
US7592459B2 (en) * | 2004-09-29 | 2009-09-22 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
US20090171094A1 (en) * | 2005-07-15 | 2009-07-02 | Kazuhide Ashizawa | 1-benzyl-4-[(5, 6-dimethoxy- 1- indanon)- 2- yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
US20100113793A1 (en) * | 2006-03-20 | 2010-05-06 | Ind-Swift Laboratories Limited | Process for the Preparation of Highly Pure Donepezil |
GB0609835D0 (en) * | 2006-05-18 | 2006-06-28 | Pliva Istrazivanje I Razvoj D | Impurities of a pharmaceutical product |
CN101167697B (zh) * | 2006-10-26 | 2011-03-30 | 中国科学院上海药物研究所 | 多奈哌齐类化合物长效缓控释组合物及其制备方法 |
EP2204364B1 (en) * | 2007-09-28 | 2013-03-20 | Tianjin Hemay Bio-Tech Co., Ltd. | Polymorphs of donepezil salts, preparation methods and uses thereof |
WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
US20140243278A1 (en) * | 2011-07-05 | 2014-08-28 | Sunil Sadanand Nadkarni | Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof |
EP2586436A1 (en) | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
WO2013078608A1 (en) * | 2011-11-29 | 2013-06-06 | Ziqiang Gu | Donepezil pamoate and methods of making and using the same |
KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
US11197850B2 (en) | 2017-02-23 | 2021-12-14 | Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor |
US20220023276A1 (en) * | 2018-11-26 | 2022-01-27 | Industry-Academic Cooperation Foundation, Yonsei University | Donepezil eutectic mixture and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
PT1086706E (pt) * | 1999-03-31 | 2004-02-27 | Eisai Co Ltd | Composicao estabilizada que compreende um medicamento nootropico |
DE60034577T2 (de) * | 1999-09-01 | 2007-12-27 | Eisai R&D Management Co., Ltd. | In 4-stellung substituierte piperidinderivate |
JP4150519B2 (ja) * | 2000-04-13 | 2008-09-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 1−ベンジルピリジニウム塩を含有してなるアセチルコリンエステラーゼ阻害剤 |
US7439365B2 (en) * | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
-
2004
- 2004-09-15 HU HU0401850A patent/HUP0401850A3/hu unknown
-
2005
- 2005-09-12 EA EA200700637A patent/EA200700637A1/ru unknown
- 2005-09-12 PL PL382842A patent/PL382842A1/pl not_active Application Discontinuation
- 2005-09-12 EP EP05787910A patent/EP1817286A1/en not_active Withdrawn
- 2005-09-12 UA UAA200704106A patent/UA88481C2/ru unknown
- 2005-09-12 CN CNA2005800348076A patent/CN101039910A/zh active Pending
- 2005-09-12 SK SK5034-2007A patent/SK50342007A3/sk not_active Application Discontinuation
- 2005-09-12 RU RU2007114082/04A patent/RU2382032C2/ru not_active IP Right Cessation
- 2005-09-12 CZ CZ20070248A patent/CZ2007248A3/cs unknown
- 2005-09-12 WO PCT/HU2005/000102 patent/WO2006030249A1/en active Application Filing
- 2005-12-09 US US11/662,867 patent/US20080194628A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181827A patent/IL181827A0/en unknown
- 2007-04-13 BG BG109855A patent/BG109855A/bg unknown
- 2007-04-16 NO NO20071912A patent/NO20071912L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL181827A0 (en) | 2007-07-04 |
US20080194628A1 (en) | 2008-08-14 |
EA200700637A1 (ru) | 2007-08-31 |
EP1817286A1 (en) | 2007-08-15 |
SK50342007A3 (sk) | 2007-07-06 |
UA88481C2 (ru) | 2009-10-26 |
PL382842A1 (pl) | 2008-01-21 |
RU2382032C2 (ru) | 2010-02-20 |
NO20071912L (no) | 2007-06-07 |
WO2006030249A1 (en) | 2006-03-23 |
BG109855A (bg) | 2008-04-30 |
CN101039910A (zh) | 2007-09-19 |
HU0401850D0 (en) | 2004-11-29 |
RU2007114082A (ru) | 2008-10-27 |
CZ2007248A3 (cs) | 2007-06-20 |
HUP0401850A2 (en) | 2006-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL177480A0 (en) | Pharmaceutical composition | |
ZA200606229B (en) | A pharmaceutical composition | |
GB2423711B (en) | Method for preparing a pharmaceutical composition with enhanced mucoadhesion | |
EP2016941A4 (en) | PREPARATION OF TRANSDERMALLY RESORBABLE DONEPZIL | |
IL181827A0 (en) | Donepezil salts suitable for the preparation of pharmaceutical compositions | |
LT1729739T (lt) | Kietos farmacinės kompozicijos gamybos būdas | |
EP1941896A4 (en) | COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION | |
EP1778252A4 (en) | NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS | |
HUP0500683A2 (en) | New arylpiprazole salts for producing pharmaceutical composition | |
HU0401177D0 (en) | Pharmaceutical composition | |
GB2411355B (en) | Pharmaceutical composition | |
GB0400452D0 (en) | A pharmaceutical composition | |
HK1098059A1 (en) | Composition comprising itraconazole for oral administration | |
ZA200701932B (en) | Pharmaceutical composition | |
GB0425255D0 (en) | Pharmaceutical composition | |
ZA200701931B (en) | Pharmaceutical composition | |
GB0428554D0 (en) | Pharmaceutical compounds | |
GB0424742D0 (en) | Pharmaceutical compounds | |
ZA200705079B (en) | Novel pharmaceutical composition useful for vaccines | |
GB0409133D0 (en) | Methods for preparing pharmaceutical compositions | |
GB0402799D0 (en) | Pharmaceutical composition | |
GB0425256D0 (en) | Pharmaceutical composition | |
GB0425259D0 (en) | Pharmaceutical composition | |
GB0321608D0 (en) | Methods for preparing pharmaceutical compositions | |
GB0506018D0 (en) | Preparation for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |